EP3981437

NUCLEIC ACID VACCINES

Filed

Apr 23, 2015

Technology

Chemistry · Pharmaceuticals

UPC cases

EPO proceedings

Ownership history

As recorded at the EPO. Transfers made after the opposition period are recorded in national registers and may be missing here.

ModernaTX, Inc.since Mar 11, 2022

Abstract

The invention relates to compositions and methods for the preparation, manufacture and therapeutic use ribonucleic acid vaccines (NAVs) comprising polynucleotide molecules encoding one or more antigens.

Litigation history

Date	Case	Division	Type	Outcome	Parties
Sep 7, 2026	UPC CFI 3215/2026	Hamburg LD	Infringement	Locked	ModernaTX, Inc. +30

Additional proceedings on this patent

Start 14-day free trialOutcomes, the additional proceedings and the register history.Already a user? Sign in